ID: ALA107792

Max Phase: Preclinical

Molecular Formula: C14H15O3P

Molecular Weight: 262.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccccc1C(c1ccccc1)P(=O)(O)O

Standard InChI:  InChI=1S/C14H15O3P/c1-11-7-5-6-10-13(11)14(18(15,16)17)12-8-3-2-4-9-12/h2-10,14H,1H3,(H2,15,16,17)

Standard InChI Key:  IQUGVYDMGPYRSD-UHFFFAOYSA-N

Associated Targets(Human)

Prostatic acid phosphatase 71 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 262.25Molecular Weight (Monoisotopic): 262.0759AlogP: 3.26#Rotatable Bonds: 3
Polar Surface Area: 57.53Molecular Species: ACIDHBA: 1HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.60CX Basic pKa: CX LogP: 2.86CX LogD: 0.48
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.83Np Likeness Score: -0.19

References

1. Schwender CF, Beers SA, Malloy EA, Cinicola JJ, Wustrow DJ, Demarest KD, Jordan J.  (1996)  Benzylphosphonic acid inhibitors of human prostatic acid phosphatase,  (3): [10.1016/0960-894X(96)00018-2]

Source